T0: before treatment begins T1: at the end of treatment or discharge from the hospital T2: 3-6 months after the end of treatment T3: 10-14 months after the end of treatment For patients receiving sequentially ceftriaxone followed by a FQ, an additional sample will be collected at the end of ceftriaxone treatment.